Related Experiment Videos
Anesthetic considerations in the child with Gaucher disease
1Department of Pediatrics, Vanderbilt University, Nashville, TN 37232.
Journal of Clinical Anesthesia
|March 1, 1993
Summary
Anesthetic management for Gaucher disease requires careful consideration of potential complications. Preoperative assessment of end-organ dysfunction is crucial for safe pediatric surgical care.
Area of Science:
- Biochemistry
- Genetics
- Pediatric Anesthesiology
Background:
- Gaucher disease is an inherited metabolic disorder caused by deficient glucosylceramide beta-glucosidase activity.
- This deficiency leads to the accumulation of glycosphingolipids, causing progressive end-organ damage.
- Three clinical variants exist, differing in onset, central nervous system (CNS) involvement, and prevalence.
Observation:
- A 7-month-old girl with Gaucher disease underwent anesthesia for laryngoscopy, bronchoscopy, and central line placement.
- Potential anesthetic concerns include CNS dysfunction (seizures, aspiration risk), upper airway obstruction from glycolipid infiltration, and bleeding risks due to hypersplenism (thrombocytopenia, anemia).
Findings:
- Gaucher disease presents significant anesthetic challenges due to multi-system involvement.
- Anesthesiologists must be aware of specific risks associated with CNS, airway, and hematologic complications.
- Preoperative evaluation is key to identifying and managing these risks.
Implications:
- Early identification of end-organ dysfunction in pediatric Gaucher disease patients is vital for anesthetic planning.
- This case highlights the importance of a multidisciplinary approach for managing complex pediatric cases.
- Optimizing preoperative assessment can ensure safer anesthetic delivery and improved patient outcomes.